细针穿刺活检在Ⅱ～Ⅲ期宫颈癌放疗中的临床应用  

Fine needle biopsy in Ⅱ-phase Ⅲ cervical cancer radiotherapy in clinical application

作　　者：白雪莲[1] 武云[1] 刘波[1] 郝志强[1] 于德东[1] 

机构地区：[1]包头市中心医院肿瘤科,014040

出　　处：《中国实用医药》2013年第1期31-32,共2页China Practical Medicine

摘　　要：目的通过对Ⅱ～Ⅲ期宫颈癌放疗后宫颈细针穿刺活检结果,探讨宫颈癌放疗剂量及疗效的临床意义。方法对23例放疗或同步放化疗的宫颈癌患者放疗A点剂量达70～75gy后,在宫颈原发病灶部位行细针穿刺活检,达PCR的患者停止放疗,未达PCR的患者继续放疗,放疗剂量增加至75～85gy。结果 23例患者治疗后病理结果达PCR的有15例,未达PCR的有8例,此8例患者继续给予后装近距离照射补量5～10gy后再次活检,病理达PCR。23例患者穿刺均未出现出血及感染等并发症。结论细针穿刺活检有操作简单易行,创伤小,并发症少,患者痛苦小易接受等优点,且获得的病理诊断对宫颈癌的治疗有重要的临床指导意义。Objective This paper discusses the cervical cancer radiotherapy dose and curative effect of clinical significance by cervical fine needle biopsy results from phase Ⅱ~Ⅲ cervical cancer after radiotherapy.Methods 23 patients who were cervical cancer,radiation or synchronous radiation and chemotherapy after radiotherapy point A dose of 70~75 Gy,we do fine needle biopsy in cervical primary focal areas,the PCR patients stop radiation therapy,outstanding PCR patients continue to radiation therapy,radiation dose increased to 75~85 Gy.Results There were 15 patients＇results reaching PCR in all after treatment pathologic,outstanding PCR have 8 cases,the 8 patients continue to offer afterloading close exposure complement quantity 5~10 Gy again after biopsy,pathology of PCR.23 patients puncture did not appear bleeding and infection complications.Conclusion Fine needle biopsy has simple operation and easy,small trauma,less complications,little pain easy to accept etc,and obtain the pathological diagnosis of cervical cancer treatment has important clinical significance.

关 键 词：宫颈癌 活检穿刺 疗效评价 放疗剂量 

分 类 号：R737.33[医药卫生—肿瘤]